GLP-1 receptor agonists were associated with improved survival and reduced graft loss among kidney transplant recipients with type 2 diabetes.

The rising use of GLP-1 agonists to help manage the obesity epidemic is not only reshaping how consumers taking the ...

GLP-1 RAs are very effective at lowering blood sugar levels. As an added bonus, some have also shown benefits for heart health and kidney function. However, some people may be better suited to ...

expressing a large concentration of GLP-1 receptors. Although increased Treg numbers and enhanced suppressive function are seen with LD IL-2 treatment, their longevity and suppressive function can ...

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

A major new study finds that certain diabetes medications, including GLP-1 and SGLT2 inhibitors ... but also for cardiovascular, kidney, and weight loss benefits. Earlier lab and population ...

People who take weight-loss drugs based on GLP-1 receptor agonists seem to have reduced risk for a litany of diseases, including Alzheimer's, but an increase in some other conditions like kidney ...

GLP-1 agonists also were tied to 12% reduced risk for acute kidney injury and 3% lower risk ... and a stabilizing effect on endothelial function, which may be driving cardiovascular benefits ...

Semaglutide was developed to mimic the multifunctional hormone glucagon-like peptide-1 (GLP-1) as a way to help ameliorate the ... links between use of semaglutide in non-diabetics to kidney or heart ...

chronic kidney disease, or sarcopenia/frailty, particularly those who have experienced an inflammatory acute medical event such as a fall or bone fracture and are on GLP-1 medications. According to ...